Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Cytotherapy|April 10, 2016
A relativity concept in mesenchymal stromal cell manufacturingIvan Martin, Jan De Boer, Luc Sensebe, et al.Cytotherapy|April 23, 2013
Immunological characterization of multipotent mesenchymal stromal cells--The International Society for Cellular Therapy (ISCT) working proposalMauro Krampera, Jacques Galipeau, Yufang Shi, et al.Cytotherapy|October 22, 2016
Spatial and temporal structure of the clinical research based on mesenchymal stromal cells: A network analysisPaul Monsarrat, Philippe Kemoun, Jean-Noel Vergnes, et al.Cytotherapy|July 24, 2009
Impaired differentiation potential of human trabecular bone mesenchymal stromal cells from elderly patientsPatrick Coipeau, Philippe Rosset, Alain Langonne, et al.Proteomics|March 5, 2004
Proteomics of methylene blue photo-treated plasma before and after removal of the dye by an absorbent filterDavid Crettaz, Luc Sensebe, Dinh-Hao Vu, et al.Clinical Endocrinology|October 23, 2002
Hodgkin's disease masquerading as fibrous thyroiditis: potential role of cytokines in in vivo and in vitro studiesJean Pierre Bercovici, Veronique Machelon, Françoise Gaudin-Nome, et al.Cytotherapy|August 26, 2010
Defining the risks of mesenchymal stromal cell therapyDarwin J Prockop, Malcolm Brenner, Willem E Fibbe, et al.Stem Cells Translational Medicine|May 25, 2016
Adipose Mesenchymal Stromal Cell-Based Therapy for Severe Osteoarthritis of the Knee: A Phase I Dose-Escalation TrialYves-Marie Pers, Lars Rackwitz, Rosanna Ferreira, et al.Biomaterials|January 9, 2021
In vitro bone metastasis dwelling in a 3D bioengineered nicheWeijing Han, Rania El Botty, Elodie Montaudon, et al.Cytotherapy|January 3, 2016
International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trialsJacques Galipeau, Mauro Krampera, John Barrett, et al.Pageof 1